Healthcare

Alibaba Health runs one of China’s largest online healthcare platforms, combining medicine retail with digital health services. Revenue and profit have climbed steadily, cash generation is strong, and its Alibaba ecosystem ties give it unusual scale in a growing market.

Bausch + Lomb is a diversified eye health company spanning contact lenses, surgical products, and prescription eye treatments. Its broad reach and exposure to aging-driven demand make the business worth a closer look, especially as revenue keeps growing across a resilient healthcare niche.

Adaptive Biotechnologies is building a healthcare platform around immune-system sequencing, with clonoSEQ cancer monitoring and pharma collaborations driving growth. Revenue and cash burn trends have improved markedly, making its commercial progress increasingly important to watch.

Aspen Pharmacare is a global drugmaker with a growing emphasis on specialized manufacturing and a strong footprint in emerging markets. The shares stand out for low valuation, useful production assets, and solid cash generation despite uneven recent earnings.

Ansell makes protective gloves and safety products for hospitals and industrial users worldwide. Revenue, margins, and cash flow have improved sharply, while its push toward more specialized protection markets gives the business a stronger profile than a pure commodity glove supplier.

Demant is a global hearing healthcare specialist combining hearing aids, clinics, and diagnostics. Strong returns on capital, healthy cash generation, and exposure to aging populations make it a compelling company to examine, even as execution and debt remain central points to watch.